Clinical Trials Browser

Solid Tumors × Other solid neoplasm × Clear all

NCT06066424 2026-04-16

Phase 1 Dose Escalation and Expansion Study of TROP2 CAR Engineered IL15-transduced Cord Blood-derived NK Cells in Patients With Advanced Solid Tumors (TROPIKANA)

Phase 1 Recruiting

Other solid neoplasm

Solid Tumors

NCT06082960 2026-04-16

Study of GS-9911 With or Without Antibody Treatment for Adults With Solid Tumors

Phase 1 Active not recruiting

Other solid neoplasm

Solid Tumors

NCT07181681 2026-04-15

A First-in-Human Study of BG-C0902 Alone and in Combination With Other Therapeutic Agents in Patients With Advanced Solid Tumors

Phase 1 Recruiting

Other solid neoplasm

Solid Tumors

NCT07395258 2026-04-15

A Study to Test Different Doses of BI 3923948 Alone and in Combination With an Anti-PD-1 Antibody in People With Different Types of Advanced Cancer (Solid Tumors)

Phase 1 Recruiting

Other solid neoplasm

Solid Tumors

NCT05155332 2026-04-14

A Study to Test Different Doses of BI 1831169 Alone and in Combination With an Anti-PD-1 Antibody in People With Different Types of Advanced Cancer (Solid Tumors)

Phase 1 Recruiting

Other solid neoplasm

Solid Tumors

NCT07529002 2026-04-14

Clinical Application of 89Zr-s-C1 PET/CT Imaging in Solid Tumors

Other solid neoplasm

Solid Tumors

NCT06885281 2026-04-09

A Study of ZL-1310 in Participants With Selected Solid Tumors

Phase 1/2 Recruiting

Other solid neoplasm

Solid Tumors

NCT06892379 2026-04-08

A Study of HS-20110 in Participants With Advanced Solid Tumors

Phase 1 Recruiting

Other solid neoplasm

Solid Tumors

NCT07415031 2026-04-08

A Solid Tumor Study for Long Term Treatment of Cancer Patients Who Participated in Adagrasib Studies

Phase 2 Not yet recruiting

Other solid neoplasm

Solid Tumors

NCT05203172 2026-04-07

The FLOTILLA Study: Providing Continued Access to The Study Medicines Encorafenib and Binimetinib for Participants in Prior Clinical Trials

Phase 4 Recruiting

Other solid neoplasm

Solid Tumors

NCT03917381 2026-04-06

GEN1046 Safety Trial in Patients With Malignant Solid Tumors

Phase 1/2 Active not recruiting

Other solid neoplasm

Solid Tumors

NCT04589845 2026-04-02

Tumor-agnostic Precision Immuno-oncology and Somatic Targeting Rational for You (TAPISTRY) Platform Study

Phase 2 Active not recruiting

920 enrolled 2 FDA

Other solid neoplasm

Solid Tumors

NCT04303858 2026-04-01

A Study to Evaluate Safety and Anti-Tumor Activity of Eciskafusp Alfa (RO7284755) Alone or in Combination With Atezolizumab in Participants With Advanced and/or Metastatic Solid Tumors

Phase 1 Completed

Other solid neoplasm

Solid Tumors

NCT07505069 2026-04-01

Exploring the Clinical Value of RT01-89Zr PET Imaging in Solid Tumors

Phase EARLY_PHASE1 Recruiting

Other solid neoplasm

Solid Tumors

NCT07176975 2026-03-31

A Study to Test How Well Different Doses of BI 1831169 in Combination With an Anti-PD1 Antibody Are Tolerated in Japanese People With Different Advanced Cancers

Phase 1 Not yet recruiting

Other solid neoplasm

Solid Tumors

NCT06805461 2026-03-30

PumaRx

Other solid neoplasm

Solid Tumors

NCT06873789 2026-03-25

A Study to Evaluate INCB177054 in Participants With Select Advanced or Metastatic Solid Tumors

Phase 1/2 Active not recruiting

Other solid neoplasm

Solid Tumors

NCT06651593 2026-03-24

Phase II Biomarker Study of SAR444881 in Combination With Cemiplimab in Solid Tumors

Phase 2 Recruiting

Other solid neoplasm

Solid Tumors

NCT07032077 2026-03-20

A Clinical Trial of HRS-7058 Combined Anti-tumor Drugs in Subjects With Solid Tumors

Phase 2 Recruiting

Other solid neoplasm

Solid Tumors

NCT02789228 2026-03-19

REST

Phase 1 Active not recruiting

Other solid neoplasm

Solid Tumors

NCT03347318 2026-03-19

PROFILING

Active not recruiting

Other solid neoplasm

Solid Tumors

NCT05101070 2026-03-18

aCCeleR8-001

Phase 1/2 Recruiting

Other solid neoplasm

Solid Tumors

NCT04261413 2026-03-11

Phase Ia/Ib Study of RS-0139 in Patients With a Recurrent, Locally Advanced or Metastatic Solid Tumors

Phase 1 Completed

Other solid neoplasm

Solid Tumors

NCT07018622 2026-03-11

DAPA-ARMOR

Phase 2 Recruiting

Other solid neoplasm

Solid Tumors

NCT03313778 2026-03-04

KEYNOTE-603

Phase 1 Active not recruiting

Other solid neoplasm

Solid Tumors

NCT03448042 2026-02-27

A Study of Runimotamab in Participants With Locally Advanced or Metastatic HER2-Expressing Cancers

Phase 1 Active not recruiting

Other solid neoplasm

Solid Tumors

NCT07030959 2026-02-25

Study of AUBE00 in Patients With Solid Tumors

Phase 1 Recruiting

Other solid neoplasm

Solid Tumors

NCT04250155 2026-02-24

An Open-Label Dose-Escalation Study to Evaluate XmAb24306 as a Single Agent and in Combination With Atezolizumab in Participants With Locally Advanced or Metastatic Solid Tumors

Phase 1 Active not recruiting

Other solid neoplasm

Solid Tumors

NCT07417501 2026-02-18

Lenvatinib Plus PD-1 Inhibitor for Advanced Solid Tumors With 11q13 Amplification

Phase 2 Not yet recruiting

Other solid neoplasm

Solid Tumors

NCT07123103 2026-02-17

A Study of XB371 Administered in Participants With Locally Advanced or Metastatic Solid Tumors

Phase 1 Recruiting

Other solid neoplasm

Solid Tumors

NCT02320435 2026-02-12

A Safety and Efficacy Extension Study of Pertuzumab in Patients With Solid Tumors Previously Enrolled in a Hoffmann-La Roche-Sponsored Pertuzumab Clinical Trial

Phase 3 Active not recruiting

Other solid neoplasm

Solid Tumors

NCT07407985 2026-02-12

GK01IIT-TZ03

Phase 1 Active not recruiting

Other solid neoplasm

Solid Tumors

NCT05982873 2026-02-06

Expanded Access to Telisotuzumab Adizutecan

Other solid neoplasm

Solid Tumors

NCT05372367 2026-02-03

A Study in People With Advanced Cancer to Test Whether the Amount of BI 907828 in the Blood is Influenced by Taking an OATP Inhibitor or a CYP3 Inhibitor

Phase 1 Completed

Other solid neoplasm

Solid Tumors

NCT05419375 2026-02-03

Screening Study for Participants With Malignant Tumors

Phase 2 Completed

Other solid neoplasm

Solid Tumors

NCT04627740 2026-01-20

Anti-ALPP CAR-T Cells Immunotherapy for Advanced Solid Tumors

Phase 1/2 Completed

Other solid neoplasm

Solid Tumors

NCT07351903 2026-01-20

GUARDIAN-02

Phase 1 Recruiting

Other solid neoplasm

Solid Tumors

NCT00777582 2026-01-13

Phase I Comparative Bioavailability Study

Phase 1 Active not recruiting

Other solid neoplasm

Solid Tumors

NCT07312903 2026-01-12

DPTX3186 in Wnt Pathway Activated Solid Tumors

Phase 1 Recruiting

Other solid neoplasm

Solid Tumors

NCT07231211 2026-01-09

A Study of SHR-4610 Injection in Patients With Advanced Solid Tumors

Phase 1/2 Recruiting

Other solid neoplasm

Solid Tumors

NCT07265622 2025-12-29

First-in-human Study of 7MW4911 in Patients With Advanced Solid Tumors

Phase 1/2 Recruiting

Other solid neoplasm

Solid Tumors

NCT06227377 2025-12-24

QTX3034 in Patients With KRAS G12D Mutation

Phase 1 Recruiting

Other solid neoplasm

Solid Tumors

NCT05836324 2025-12-18

A Study to Evaluate the Safety of INCA33890 in Participants With Advanced or Metastatic Solid Tumors

Phase 1 Recruiting

Other solid neoplasm

Solid Tumors

NCT06727812 2025-12-18

Multicenter Phase I Study of HRS-6208 in Patients With Solid Tumors

Phase 1 Recruiting

Other solid neoplasm

Solid Tumors

NCT05471856 2025-12-17

A Study to Test How Different Doses of BI 1703880 in Combination With Ezabenlimab Are Tolerated in People With Different Types of Advanced Cancer (Solid Tumours)

Phase 1 Recruiting

Other solid neoplasm

Solid Tumors

NCT07159126 2025-12-10

A Study of DS3610a in Participants With Advanced Solid Tumor

Phase 1 Recruiting

Other solid neoplasm

Solid Tumors

NCT07274085 2025-12-10

A Phase 1 Study of HDM2017 in Advanced Solid Tumors

Phase 1 Recruiting

Other solid neoplasm

Solid Tumors

NCT07105215 2025-11-26

A I/II Phase Clinical Study to Evaluate the Safety and Efficacy of RC278 in the Treatment of Solid Tumors

Phase 1/2 Recruiting

Other solid neoplasm

Solid Tumors

NCT07231081 2025-11-17

Phase I Study of TX103 CAR-T Cells in Participants With Advanced Solid Tumors

Phase 1 Recruiting

Other solid neoplasm

Solid Tumors

NCT07178938 2025-11-14

THERANOVA

Phase 2 Not yet recruiting

BreastOther solid neoplasm

Solid Tumors